Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cell”

501 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 501 results

Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Not applicableNot Yet RecruitingNCT07409168
What this trial is testing

Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Sun Yat-sen University 100
Early research (Phase 1)Ended earlyNCT05712278
What this trial is testing

Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia
Sanofi 7
Testing effectiveness (Phase 2)Study completedNCT06331624
What this trial is testing

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisIPF
GRI Bio Operations, Inc. 35
Large-scale testing (Phase 3)UnknownNCT00846157
What this trial is testing

Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
NKBio Co.Ltd. 276
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Testing effectiveness (Phase 2)UnknownNCT03242603
What this trial is testing

Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells

Who this might be right for
Neuroblastoma Recurrent
National University Hospital, Singapore 5
Testing effectiveness (Phase 2)Looking for participantsNCT06026657
What this trial is testing

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Negative Breast Carcinoma
Margaret Gatti-Mays 42
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07589530
What this trial is testing

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid TumorsTROP2-Expressing Solid Tumors
Beijing Biotech 60
Early research (Phase 1)Active Not RecruitingNCT03774654
What this trial is testing

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Who this might be right for
Refractory B-Cell Non-Hodgkin LymphomaRefractory B-Cell Small Lymphocytic LymphomaRelapsed Adult ALL+2 more
Baylor College of Medicine 13
Not applicableUnknownNCT00692809
What this trial is testing

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection

Who this might be right for
Latent Tuberculosis InfectionHIV InfectionsTuberculosis
Ministry of Science and Technology, India 180
Early research (Phase 1)Study completedNCT03346499
What this trial is testing

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

Who this might be right for
HIV
University of Minnesota 4
Early research (Phase 1)Looking for participantsNCT06568328
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Who this might be right for
Graft vs Host Disease
Fujian Medical University 17
Testing effectiveness (Phase 2)Looking for participantsNCT05334693
What this trial is testing

Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 15
Early research (Phase 1)Looking for participantsNCT06793956
What this trial is testing

Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Extranodal Natural Killer/T Cell Lymphoma
Sun Yat-sen University 12
Not applicableUnknownNCT04423536
What this trial is testing

Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma

Who this might be right for
Natural Killer T-cell Lymphoma
Sun Yat-sen University 800
Not applicableNot Yet RecruitingNCT06988072
What this trial is testing

Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia

Who this might be right for
BK PolyomavirusKidney Transplant
Assistance Publique - Hôpitaux de Paris 75
Early research (Phase 1)Temporarily pausedNCT01974479
What this trial is testing

Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
National University Health System, Singapore 20
Not applicableEnded earlyNCT03164889
What this trial is testing

Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Beijing 302 Hospital 80
Load More Results